Morgan Stanley Reiterates Underweight Rating for Delek US (NYSE:DK)

Delek US (NYSE:DK - Get Free Report)'s stock had its "underweight" rating reissued by investment analysts at Morgan Stanley in a report released on Wednesday, MarketBeat.com reports. They presently have a $19.00 price target on the oil and gas company's stock, up from their previous price target of $15.00. Morgan Stanley's price target suggests a potential downside of 23.84% from the company's previous close.

Several other analysts have also recently weighed in on the stock. UBS Group reduced their target price on shares of Delek US from $21.00 to $13.25 and set a "neutral" rating on the stock in a report on Wednesday, April 9th. Citigroup reiterated a "neutral" rating and issued a $30.00 price objective (up from $15.00) on shares of Delek US in a research report on Wednesday. Mizuho upgraded shares of Delek US from a "neutral" rating to an "outperform" rating and upped their target price for the company from $22.00 to $23.00 in a report on Tuesday, May 13th. Scotiabank reissued a "sector perform" rating and set a $20.00 target price (up previously from $14.00) on shares of Delek US in a research report on Friday, July 11th. Finally, Raymond James Financial increased their price objective on shares of Delek US from $23.00 to $28.00 and gave the company an "outperform" rating in a research report on Tuesday. Five research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have assigned a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Hold" and an average price target of $19.71.

Delek US Trading Down 1.9%

Shares of DK stock traded down $0.49 during trading hours on Wednesday, reaching $24.95. 1,405,219 shares of the stock were exchanged, compared to its average volume of 1,417,336. The firm has a market capitalization of $1.52 billion, a price-to-earnings ratio of -2.25 and a beta of 0.98. The company has a current ratio of 0.85, a quick ratio of 0.53 and a debt-to-equity ratio of 7.05. Delek US has a 12-month low of $11.03 and a 12-month high of $27.07. The company's 50-day moving average price is $20.70 and its 200-day moving average price is $17.69.

Delek US (NYSE:DK - Get Free Report) last released its quarterly earnings data on Wednesday, May 7th. The oil and gas company reported ($2.32) EPS for the quarter, missing the consensus estimate of ($2.27) by ($0.05). The business had revenue of $2.64 billion during the quarter, compared to analysts' expectations of $2.56 billion. Delek US had a negative net margin of 6.10% and a negative return on equity of 63.88%. The firm's revenue was down 18.1% on a year-over-year basis. During the same period last year, the company earned ($0.41) earnings per share. As a group, equities analysts anticipate that Delek US will post -5.5 earnings per share for the current year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. SummerHaven Investment Management LLC increased its holdings in Delek US by 3.2% during the 2nd quarter. SummerHaven Investment Management LLC now owns 35,575 shares of the oil and gas company's stock worth $753,000 after purchasing an additional 1,095 shares in the last quarter. Wedge Capital Management L L P NC grew its holdings in shares of Delek US by 8.8% in the second quarter. Wedge Capital Management L L P NC now owns 39,907 shares of the oil and gas company's stock valued at $845,000 after acquiring an additional 3,241 shares in the last quarter. Kawa Capital Management Inc lifted its stake in Delek US by 72.2% in the first quarter. Kawa Capital Management Inc now owns 400,000 shares of the oil and gas company's stock valued at $6,192,000 after purchasing an additional 167,750 shares during the last quarter. Rhumbline Advisers lifted its stake in Delek US by 3.4% in the first quarter. Rhumbline Advisers now owns 121,201 shares of the oil and gas company's stock valued at $1,826,000 after purchasing an additional 4,031 shares during the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in Delek US by 7.2% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 146,871 shares of the oil and gas company's stock valued at $2,213,000 after purchasing an additional 9,827 shares during the last quarter. 97.01% of the stock is owned by institutional investors and hedge funds.

About Delek US

Delek US Holdings, Inc engages in the integrated downstream energy business in the United States. The company operates through Refining, Logistics, and Retail segments. The Refining segment processes crude oil and other feedstock for the manufacture of various grades of gasoline, diesel fuel, aviation fuel, asphalt, and other petroleum-based products that are distributed through owned and third-party product terminal.